This non-prescription test allows users to perform and get results themselves without a medical provider or laboratory needed.
The first over-the-counter at-home diagnostic test for coronavirus disease 2019 (COVID-19) was granted emergency use authorization (EUA) by the US Food and Drug Administration (FDA) yesterday. The EUA was for the Ellume COVID-19 Home Test.
FDA Commissioner Stephen M. Hahn, MD, called the EUA “a major milestone in diagnostic testing for COVID-19. By authorizing a test for over-the-counter use, the FDA allows it to be sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes.”
The FDA granted an EUA last month to Lucira Health for it’s at-home, self-administered COVID test which can be purchased with a prescription. Since the beginning of the pandemic, the agency has authorized more than 225 COVID-19 diagnostic tests, including more than 25 tests that allow for home collection of samples, which are then sent to a lab for testing.
“As we continue to authorize additional tests for home use, we are helping expand Americans’ access to testing, reducing the burden on laboratories and test supplies, and giving Americans more testing options from the comfort and safety of their own homes,” Hahn said.
The test may prove especially useful during this second wave of COVID-19.
According to the COVID Tracking Project, yesterday was a record-breaking day in terms of people being hospitalized for COVID-19: 112,816 people were hospitalized for COVID yesterday, the most ever. The next four highest days for hospitalization? They are December 14, 13, 12, and 11—the four previous days.
According to Johns Hopkins University, there were 189,357 confirmed cases of COVID-19 yesterday while 3019 people died from the disease. That’s the third highest one-day death toll for the disease in the United States since the pandemic began.
Overall, in the United States there have been nearly 17 million confirmed cases of COVID-19. And, in the United States, over 300,000 people have died from the disease. In the world, there have been over 70 million confirmed cases of COVID-19. And, in the world, over 1.6 million people have died from the disease.
This story originally appeared in Contagion®.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.